Frontiers in Clinical Drug Research-Anti-Infectives

Volume 5

by

Atta-ur-Rahman

DOI: 10.2174/97816810863781190501
eISBN: 978-1-68108-637-8, 2019
ISBN: 978-1-68108-638-5
ISSN: 2452-3208 (Print)
ISSN: 2352-3212 (Online)



Indexed in: Scopus

Frontiers in Clinical Drug Research – Anti infectives is a book series that brings updated reviews to readers interested in learning a...[view complete introduction]
US $
Buy Personal Book
79
Order Library Book
316
Order Printed Copy
*119
Order PDF + Printed Copy (Special Offer)
*158

*(Excluding Mailing and Handling)

🔒Secure Checkout Personal information is secured with SSL technology

Therapeutic Use of Commensal Microbes: Fecal/Gut Microbiota Transplantation

- Pp. 41-110 (70)

Patricia A. Vanny, Aline Machiavelli, Catherine W. Wippel, Jéssica de Andrade, Caetana P. Zamparette, Daniela C. Tartari, Thaís C.M. Sincero, Aguinaldo R. Pinto and Carlos R. Zárate-Bladés

Abstract

Recognition of the microbial component of human physiology has gained attention in recent years. Several discoveries in different medical disciplines about the participation of commensal microorganisms, broadly known as the microbiota, have guided both basic research and the development of novel therapeutic strategies. In parallel, the broad use of antibiotics has directly impacted microbiota composition with collateral effects, such as the emergence of antibiotic-associated diarrheas (AADs), with the best example being intestinal infection with Clostridium difficile. An ancient Chinese methodology called “fecal microbiota transplantation (FMT)” – referred to here as “gut microbiota transplantation (GMT)” – is currently being used around the world with impressive success against recurrent C. difficile infections (CDIs). This success has inspired several investigators to test this microbiota-based therapy in other conditions, including non-infectious diseases. We introduce this chapter with a review on the main microbiota effects on human health and the immune system. Then, a comprehensive discussion of GMT is provided including the pathogenesis of CDI, GMT history, methodology and ethical aspects, followed by a review of clinical and experimental studies on the therapeutic effects and mechanisms of GMT against recurrent CDI. Finally, GMT testing in other conditions is discussed.

Purchase Chapter  Book Details

Advertisement

Special New Year Discount

Webmaster Contact: info@benthamscience.net Copyright © 2019 Bentham Science